Pharma and Biotech
| Period Ending | Period | Revenue ( m) | Pre-tax ( m) | EPS | Dividend |
|---|---|---|---|---|---|
| 30-Jun-26 | Interim | n/a | 1.20 | (6.11)¢ | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | n/a | (5.25) | (19.29)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | n/a | (5.61) | (20.64)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | n/a | (5.10) | (0.18)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | n/a | n/a | (0.09)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-25 | n/a | (1.57) | (5.34)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Forecasts data is not available for this company.
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| 5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
|---|---|---|---|---|
| Latest | n/a | n/a | n/a | 0 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
| Currency | UK Pounds |
| Share Price | 7.75p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 8.00p |
| 52 Week Low | 7.50p |
| Volume | 5,915 |
| Shares Issued | 71.34m |
| Market Cap | £5.53m |
| Value |
|
|---|
| Value |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:39 | 280 @ 7.50p |
| 10:11 | 5,563 @ 7.52p |
| 09:01 | 60 @ 7.50p |
| 08:49 | 12 @ 8.00p |
| CEO | Timothy McCutcheon |
| CFO | Leah Ellen O’Donovan |
You are here: research